share_log

Vertex Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Director Schneider Jennifer

SEC announcement ·  May 18 04:22
Summary by Futu AI
Jennifer Schneider, a director at Vertex Pharmaceuticals Incorporated, filed an Initial Statement of Beneficial Ownership of Securities with the SEC, as per Form 3 requirements. The document, dated 05/15/2024, indicates that Schneider does not beneficially own any securities in the company. The filing, completed on 05/17/2024, is a routine disclosure for directors and was submitted in accordance with Section 16(a) of the Securities Exchange Act of 1934. This formality is part of the regulatory compliance for individuals in Schneider's position, ensuring transparency in the ownership of securities related to the company.
Jennifer Schneider, a director at Vertex Pharmaceuticals Incorporated, filed an Initial Statement of Beneficial Ownership of Securities with the SEC, as per Form 3 requirements. The document, dated 05/15/2024, indicates that Schneider does not beneficially own any securities in the company. The filing, completed on 05/17/2024, is a routine disclosure for directors and was submitted in accordance with Section 16(a) of the Securities Exchange Act of 1934. This formality is part of the regulatory compliance for individuals in Schneider's position, ensuring transparency in the ownership of securities related to the company.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Doc 2

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.